Description
CANCER TESTS: DE-OBLIGATE FUNDS CLOSEOUT CONTRACT MODIFICATION
Base award description: TVHS - BREAST AND PROSTATE CANCER TESTING.
Modification chain · 14 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-10-01+$61,710= $61,710
- Mod P000012020-07-13-$2,410= $59,300
- Mod P000022020-10-01+$61,710= $121,010
- Mod P000032021-02-01+$2,088= $123,098
- Mod P000042021-03-25-$19,419= $103,679
- Mod P000052021-10-01+$61,710= $165,389
- Mod P000062022-03-07-$36,166= $129,223
- Mod P000082022-10-01+$61,710= $190,933
- Mod P000092023-04-05-$322= $190,611
- Mod P000102023-05-25-$51,609= $139,002
- Mod P000112023-10-01+$61,710= $200,712
- Mod P000122023-10-23-$20,262= $180,450
- Mod P000132024-03-11-$37,994= $142,456
- Mod P000142025-01-29-$20,724= $121,732
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-10-01 | +$61,710 | $61,710 | TVHS - BREAST AND PROSTATE CANCER TESTING. |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-07-13 | −$2,410 | $59,300 | TVHS - BREAST AND PROSTATE CANCER TESTING. |
| Mod P00002· EXERCISE AN OPTION | 2020-10-01 | +$61,710 | $121,010 | TVHS - BREAST AND PROSTATE CANCER TESTING. |
| Mod P00003· OTHER ADMINISTRATIVE ACTION | 2021-02-01 | +$2,088 | $123,098 | TVHS - BREAST AND PROSTATE CANCER TESTING. |
| Mod P00004· OTHER ADMINISTRATIVE ACTION | 2021-03-25 | −$19,419 | $103,679 | TVHS - BREAST AND PROSTATE CANCER TESTING. |
| Mod P00005· EXERCISE AN OPTION | 2021-10-01 | +$61,710 | $165,389 | TVHS - BREAST AND PROSTATE CANCER TESTING. |
| Mod P00006· OTHER ADMINISTRATIVE ACTION | 2022-03-07 | −$36,166 | $129,223 | TVHS - BREAST AND PROSTATE CANCER TESTING. |
| Mod P00008· EXERCISE AN OPTION | 2022-10-01 | +$61,710 | $190,933 | EXERCISING OPTION YEAR 3 TVHS - BREAST AND PROSTATE CANCER TESTING. |
| Mod P00009· OTHER ADMINISTRATIVE ACTION | 2023-04-05 | −$322 | $190,611 | DECREASE FOR CLN 3001 INCREASE FOR CLIN 3002 - BREAST AND PROSTATE CANCER TESTING. |
| Mod P00010· OTHER ADMINISTRATIVE ACTION | 2023-05-25 | −$51,609 | $139,002 | DECREASE FOR CLINS 2001 AND 2002 - FOR FY 21 CLOSEOUT. |
| Mod P00011· EXERCISE AN OPTION | 2023-10-01 | +$61,710 | $200,712 | DECREASE FOR CLINS 2001 AND 2002 - FOR FY 21 CLOSEOUT. |
| Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-10-23 | −$20,262 | $180,450 | INCREASE CLIN 4001 FROM 4 TO 12 AND DECREASE CLIN 4002 FROM 15 TO 0-THIS SERVICE IS NO LONGER PROVIDED BY THE… |
| Mod P00013· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-03-11 | −$37,994 | $142,456 | INCREASE CLIN 4001 FROM 4 TO 12 AND DECREASE CLIN 4002 FROM 15 TO 0-THIS SERVICE IS NO LONGER PROVIDED BY THE… |
| Mod P00014· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-01-29 | −$20,724 | $121,732 | CANCER TESTS: DE-OBLIGATE FUNDS CLOSEOUT CONTRACT MODIFICATION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NGBXEJX5GLE9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25726N0419 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING | $127,174 | FY2026 |
| 36C25726N0252 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING | $52,215 | FY2026 |
| 36C25526N0057 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,454 | FY2026 |
| 36C25526N0054 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $24,259 | FY2026 |
| 36C25526N0056 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,454 | FY2026 |
| 36C25526N0055 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,116 | FY2026 |
Other recipients under Q301 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24926N0622 | CAREDX, INC. | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $1,049,561 | FY2026 |
| 36C24926N0546 | SYSMEX AMERICA, INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $85,874 | FY2026 |
| 36C24926N0456 | HOLOGIC SALES AND SERVICE, LLC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $28,550 | FY2026 |
| 36C24926N0479 | D & D LABORATORY LLC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $18,817 | FY2026 |
| 36C24926P0132 | NATIONAL MARROW DONOR PROGRAM | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $2,000,000 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24920F0033_3600_V797D70053_3600 · retrieved 2026-09-26.